There are about 6,000 diseases identified as “rare” affecting approximately 300 million people worldwide.

We in the pharmaceutical industry have much to learn from these patients about the challenges they face to achieve their best health and well-being, especially from patients’ real voice.

Innovation starts from the passion to know.
I hope we take Rare Disease Day as an opportunity to learn about these patients’ journey to find the right diagnoses and care for themselves and their families.

We believe our pursuit of innovation and exploration of scientific discovery will deliver life-changing value for those living with rare diseases and bring smiles to our patients.

Masashi Miyamoto
Chief Executive Officer, Kyowa Kirin

More Kyowa Kirin "Patients" Stories

Kyowa Kirin celebrates Rare Disease Day 2024 across the world

Patients | February 9, 2024

Kyowa Kirin CEO Miyamoto’s New Year Message

Growth | January 9, 2024

Kyowa Kirin Chief International Business Officer Abdul Mullick’s Message on UN’s International Day of Persons with Disabilities

Sustainability | December 1, 2023

Kyowa Kirin hosted a booth for the first time at the Tokyo Rainbow Pride 2023 [Our Diversity, Equity & Inclusion]

People & Culture | November 9, 2023

Our Stable Supply of High-quality Pharmaceuticals

Sustainability | September 20, 2023

Provide pharmaceuticals for unmet medical needs - A Conversation with Kyowa Kirin’s R&D Executives

Innovation | August 22, 2023PDF file

Ensure a Thriving Global Environment for Future Generations

Sustainability | July 28, 2023

“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅡ

People & Culture | June 9, 2023

How Kyowa Kirin Celebrated Rare Disease Day 2023 around The World

Patients | May 18, 2023

“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅠ

People & Culture | April 25, 2023

Kyowa Kirin CEO Miyamoto’s Message on Rare Disease Day

Patients | February 28, 2023

Promoting patient advocacy and nurturing patient-centric care: Interview with Kyowa Kirin North America

Patients | February 14, 2023

Celebrating another year of diverse initiatives around the world: RDD 2022 in EMEA

Patients | January 24, 2023

Celebrating another year of diverse initiatives around the world: RDD 2022 in North America

Patients | December 15, 2022

Celebrating another year of diverse initiatives around the world: RDD 2022 in Asia Pacific

Patients | November 21, 2022

Celebrating another year of diverse initiatives around the world: RDD 2022 in Japan

Patients | October 20, 2022

Providing high-quality pharmaceuticals to patients around the world

Sustainability | September 22, 2022

Striving to create life-changing “Only-one value” that brings smiles to patients

Innovation | July 25, 2022

Kyowa Kirin International: It's Time to Shine A Light on XLH

Patients | June 27, 2022

Kyowa Kirin CEO Miyamoto’s Message on Pride Month

People & Culture | June 9, 2022

Kyowa Kirin International Celebrates the UN’s International Day of Persons with Disabilities in EMEA

People & Culture | January 20, 2022

Kyowa Kirin International: Around the world challenge

People & Culture | December 17, 2021Open in new window

Kyowa Kirin North America: Honoring The Caregiver, Everyday Heroes, During National Family Caregivers Month

Patients | November 19, 2021

Kyowa Kirin's Effort to Realize a Sustainable Society

Sustainability | October 11, 2021

Our Financial Strategy for Creating Life-changing Value

Growth | September 9, 2021

Changes in society caused by COVID-19 and the impact on Kyowa Kirin

Growth | August 19, 2021

Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break

Sustainability | July 27, 2021

AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS

News Release | June 1, 2021

MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting

News Release | May 20, 2021

White Paper on the unrecognized burden of XLH in adults in Europe

Patients | July 13, 2020

Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (First Half)

People & Culture | March 5, 2020

Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (Second Half)

People & Culture | March 5, 2020

“Delivering smiles with sports” Creating an inclusive society through table tennis

Sustainability | January 14, 2020

Bio Adventure*: Kyowa Kirin Invites Children to a Science Adventure

People & Culture | July 3, 2019

Return to Stories